HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruimin Hong Selected Research

Circulating Tumor DNA

1/2021Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruimin Hong Research Topics

Disease

7Neoplasms (Cancer)
04/2024 - 01/2021
5Hematologic Neoplasms (Hematological Malignancy)
04/2024 - 01/2021
5Cytokine Release Syndrome
03/2024 - 01/2021
5Multiple Myeloma
01/2023 - 01/2021
3Leukemia
04/2024 - 01/2022
3Infections
04/2024 - 01/2023
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 10/2020
2Cytopenia
01/2023 - 01/2021
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 01/2021
1Disease Progression
04/2024
1Fever (Fevers)
03/2024
1Carcinogenesis
06/2023
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2023
1Critical Illness (Critically Ill)
01/2023
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2023
1Residual Neoplasm
01/2023
1Lymphoma (Lymphomas)
01/2021
1COVID-19
01/2021
1Cauda Equina Syndrome
01/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021
1Composite Lymphoma
01/2018

Drug/Important Bio-Agent (IBA)

16Chimeric Antigen ReceptorsIBA
04/2024 - 10/2020
3CytokinesIBA
03/2024 - 01/2021
3B-Cell Maturation AntigenIBA
01/2023 - 01/2021
3bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2022 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2021
1Proteins (Proteins, Gene)FDA Link
04/2024
1Lysine (L-Lysine)FDA Link
04/2024
1MethyltransferasesIBA
04/2024
1tocilizumab (atlizumab)FDA Link
06/2023
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2023
1Circulating Tumor DNAIBA
01/2021
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021
1NF-kappa B (NF-kB)IBA
01/2021
1Interleukin-10 (Interleukin 10)IBA
01/2021
1Lenalidomide (CC 5013)FDA Link
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021

Therapy/Procedure

14Therapeutics
04/2024 - 01/2018
3Hematopoietic Stem Cell Transplantation
04/2024 - 01/2018
3Drug Therapy (Chemotherapy)
04/2024 - 01/2018
2Immunotherapy
01/2022 - 01/2021
1Aftercare (After-Treatment)
01/2023
1Immunomodulation
01/2018